A panel of judges has agreed to centralize all federally-filed Xarelto Lawsuits into a single proceeding to be established in the U.S. District Court, Eastern District of Louisiana. The complaints were filed on behalf of individuals who claim that Xarelto caused them to suffer internal bleeding episodes and other serious side effects.
Free Xarelto Lawsuit Evaluation: If you or a loved one was injured by Xarelto, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturers and we can help.
What’s the Problem?
To date, at least 21 lawsuits have been filed in federal court alleging that Xarelto caused plaintiffs to suffer life-threatening internal bleeding events and other serious complications, according to a transfer order issued Dec. 12. While the U.S. Judicial Panel on Multidistrict Litigation (JPML) has acknowledged that the pending cases did “present a number of individualized factual issues,” the judges agreed that the docket would benefit from consolidation because plaintiffs raise similar issues, “including the adequacy of Xarelto’s warning label as to the risk of severe bleeding, the results of certain clinical studies, and the alleged need for blood monitoring.”
The lawsuits allege that Xarelto’s manufacturers wrongly marketed the drug as superior to warfarin, a staple blood-thinner that’s been in use in the U.S. for more than 50 years. Additionally, the complaints note that there is no antidote to reverse bleeding with Xarelto, whereas with warfarin, a single dose of vitamin k can stop bleeding. The lawsuits further allege that the drug makers should have recommended blood monitoring for patients treated with Xarelto, so that physicians could adjust dosage to avoid high concentrations that have the potential to cause hemorrhaging.
In October, a number of plaintiffs petitioned the JPML to consolidate the lawsuits, claiming that thousands of similar cases would be filed before the litigation was complete. Consolidation is designed to avoid duplicative discovery, inconsistent rulings by different judges, and to speed things though the litigation process as quickly as possible. The Xarelto MDL is: In Re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL No. 2592.
Do I Have a Xarelto Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Xarelto lawsuits. We are handling individual litigation nationwide and currently accepting new Xarelto bleeding cases in all 50 states.
Free Confidential Lawsuit Evaluation: If you or a loved one has been injured by Xarelto, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.